Hospital Ampang (Site 3404)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Diffuse large B-cell lymphoma

Running trials

• Recruiting

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  NCT06717347· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diffuse large B-cell lymphoma1 recruiting